dc.contributor.author | Muguruza Millán, Carolina | |
dc.contributor.author | Cordero Ruiz, Natalia | |
dc.contributor.author | Meana Martínez, José Javier | |
dc.contributor.author | Ortega Calvo, Jorge | |
dc.date.accessioned | 2021-04-13T17:28:07Z | |
dc.date.available | 2021-04-13T17:28:07Z | |
dc.date.issued | 2020-11-17 | |
dc.identifier.citation | European Neuropsychopharmacology 40(Sup1) :S53-S54 (2020) | es_ES |
dc.identifier.issn | 0924-977X | |
dc.identifier.uri | http://hdl.handle.net/10810/50912 | |
dc.description.abstract | Background: A growing body of evidence support that maternal prenatal infections represent a risk factor for schizophrenia in offspring. Moreover, stressful events during critical neurodevelopmental periods, such as adolescence, may trigger the onset of the disease in predisposed individuals. Thus, a prenatal priming event (i.e. maternal infection during pregnancy) that would induce vulnerability, followed by a second stressful hit in peripuberty may lead to the onset of schizophrenia | es_ES |
dc.description.sponsorship | Disclosure statement: Supported by the Basque Government (IT1211-19), the European Union's Horizon 2020 research and innovation programme (Marie Sklodowska-Curie grant agreement No 747487) and SAF 2017-88126-R. NC is recipient of a FPI fellowship (PRE2018-084002) from MICINN. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Elsevier | es_ES |
dc.relation | info:eu-repo/grantAgreement/EC/H2020/747487 | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.title | A novel double-hit animal model of schizophrenia: behavioural assessment in male and female mice | es_ES |
dc.type | info:eu-repo/semantics/conferenceObject | es_ES |
dc.rights.holder | © 2020 Elsevier B.V.This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ | es_ES |
dc.relation.publisherversion | https://www.sciencedirect.com/science/article/pii/S0924977X20303473?via%3Dihub | es_ES |
dc.identifier.doi | 10.1016/j.euroneuro.2020.09.074 | |
dc.contributor.funder | European Commission | |
dc.departamentoes | Farmacología | es_ES |
dc.departamentoeu | Farmakologia | es_ES |